Hyperhidrosis
📧 Sign up to get email alerts when something new happens for Hyperhidrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis [Phase 3]
Phase 3 long-term safety study of glycopyrronium in subjects with primary axillary hyperhidrosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis [Phase 2]
Phase 2 dose-ranging study evaluating glycopyrrolate for axillary hyperhidrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis [Phase 2]
Phase 2 comparator trial evaluating the effects of glycopyrrolate vs glycopyrronium in subjects with axillary hyperhidrosis, with results po…
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis [Phase 3]
Phase 3 clinical trial update for glycopyrronium in axillary hyperhidrosis has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Study of Glycopyrronium in Axillary Hyperhydrosis [Phase 3]
A Phase 3 clinical trial evaluating glycopyrronium for axillary hyperhidrosis has been completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults [NA]
A pilot study investigated the efficacy and safety of topical oxybutynin 3% gel for primary focal hyperhidrosis in adolescents and young adu…
-
CLINICAL_TRIALS research · 2018-03-05Clinical Trial Update: Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis [Phase 2]
Update on a Phase 2 clinical trial investigating botulinum toxin injections for treating hyperhidrosis affecting craniofacial, inguinal, pal…
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects [Phase 2]
Phase 2 trial assessing umeclidinium for palmar hyperhidrosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis [NA]
The clinical trial evaluating the Ulthera System for primary axillary hyperhidrosis (NCT01722461) has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis [NA]
This updates on a completed feasibility study evaluating the Ulthera System for treating axillary hyperhidrosis.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis [NA]
This is a completed feasibility study evaluating the safety and efficacy of the Ulthera System for axillary hyperhidrosis.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis [Phase 2]
Phase 2 trial evaluating pharmacokinetics, safety, tolerability, and clinical effect of topical umeclidinium for primary axillary hyperhidro…
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis [Phase 2]
Phase 2 clinical trial evaluating ANT-1207 for primary axillary hyperhidrosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis [Phase 1]
Phase 1 trial evaluating microneedle-assisted botulinum toxin delivery for palmar hyperhidrosis has completed.
-
FDA approval · 2017-06-23FDA Approved: GLYCOPYRROLATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for a generic glycopyrrolate product from Somerset Therapeutics, LLC.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects [Phase 1]
Phase 1 study characterizing systemic exposure from topical [14C] umeclidinium applied to the axilla or palm in healthy male subjects.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis [NA]
This is an update on a completed clinical trial evaluating fractional micro-needle radiofrequency and botulinum toxin A for primary axillary…
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar. [NA]
This clinical trial update reports the completed study evaluating topical oxybutynin 10% for primary focal hyperhidrosis affecting the axill…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G) [Phase 1]
Phase 1 clinical trial evaluating measurement and treatment of excessive sweating caused by antidepressants using glycopyrrolate (AIDES-G); …
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin [Phase 4]
Phase 4 trial evaluating terazosin as a treatment for hyperhidrosis (excessive sweating) induced by antidepressants, including measurements …
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of a botulinum toxin type A topical gel for primary axillary hyperhidrosis has completed.
-
CLINICAL_TRIALS withdrawal · 2016-07-26Clinical Trial Update: Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis [Phase 3]
A Phase 3 trial evaluating oxybutynin chloride for primary hyperhidrosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Cardiac Autonomic Changes After Endoscopic Thoracic Sympathectomy For Essential Palmar Hyperhidrosis [NA]
A completed clinical trial update reports on cardiac autonomic changes following endoscopic thoracic sympathectomy in patients with hyperhid…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Staged Extended Thoracoscopic Sympathicotomy for Palmo-axillo-plantar Hyperhidrosis [NA]
This clinical trial update reports the completion of a staged extended thoracoscopic sympathicotomy for palmo-axillo-plantar hyperhidrosis, …
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis [Phase 2]
This completed Phase 2 trial assessed the safety and efficacy of an anticholinergic agent for treating primary axillary hyperhidrosis.